Education
About Us
Working with TipRanks
Follow Us
Valbiotis SA (FR:ALVAL)
:ALVAL
ALVAL Stock Chart & Stats
Day’s Range― - ―
52-Week Range€1.07 - €4.73
Previous CloseN/A
Volume46.53K
Average Volume (3M)64.34K
Market Cap
€20.30M
Enterprise Value€4.77M
Total Cash (Recent Filing)€7.42M
Total Debt (Recent Filing)€2.80M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Mar 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding15,794,596
10 Day Avg. Volume31,352
30 Day Avg. Volume64,337
Standard Deviation0.18
R-Squared0.00027
Alpha0.00654
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)15.02
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Valbiotis SA News
PremiumCompany Announcements
Valbiotis SA Confirms Strategic Growth and Successful Product Launch
PremiumCompany Announcements
Valbiotis Releases Monthly Voting Rights and Share Capital Data
PremiumCompany Announcements
Valbiotis Releases Monthly Voting Rights and Shares Update
PremiumCompany Announcements
Valbiotis Launches Innovative Metabolic Health Supplement in France
PremiumCompany Announcements
Valbiotis Reports Half-Year Liquidity Contract UpdatePremiumCompany Announcements
Valbiotis SA: A Promising Innovator in Health Nutrition---
ALVAL FAQ
What was Valbiotis SA’s price range in the past 12 months?
Valbiotis SA lowest stock price was €1.07 and its highest was €4.73 in the past 12 months.
What is Valbiotis SA’s market cap?
Valbiotis SA’s market cap is €20.30M.
When is Valbiotis SA’s upcoming earnings report date?
Valbiotis SA’s upcoming earnings report date is Mar 12, 2025 which is in 9 days.
How were Valbiotis SA’s earnings last quarter?
Valbiotis SA released its earnings results on Oct 29, 2024. The company reported -€0.222 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.222.
Is Valbiotis SA overvalued?
According to Wall Street analysts Valbiotis SA’s price is currently Overvalued.
Does Valbiotis SA pay dividends?
Valbiotis SA does not currently pay dividends.
What is Valbiotis SA’s EPS estimate?
Valbiotis SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Valbiotis SA have?
Valbiotis SA has 15,794,596 shares outstanding.
What happened to Valbiotis SA’s price movement after its last earnings report?
Valbiotis SA reported an EPS of -€0.222 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.065%.
Which hedge fund is a major shareholder of Valbiotis SA?
Currently, no hedge funds are holding shares in FR:ALVAL
---
Company Description
Valbiotis SA
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
---
Technical Analysis
---